Delivery of Prime editing in human stem cells using pseudoviral NanoScribes particles

Thibaut Halegua1, Valérie Risson2, Julien Carras2,3

  • 1CIRI, Centre International de Recherche en Infectiologie Univ Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, F-69007, Lyon, France.

Nature Communications
|January 4, 2025
PubMed
Summary

Researchers developed Nanoscribes, virus-like particles for precise gene editing in human stem cells. This breakthrough overcomes delivery challenges for prime editing, enabling advanced genome engineering applications.